However, recent studies suggest that CDK4/6 inhibitors can also inhibit tumor growth through additional mechanisms including modulation of mitogenic kinase signaling, induction of a senescence-like phenotype34, and enhancement of cancer cell immunogenicity37. The gene discussed is CDK4; the disease is neoplasm.